v3.22.2.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 5,781,918 $ 40,750,133
Marketable securities 20,752,290
Accounts receivable 13,842 110,141
Prepaid research and development 932,419 107,000
Prepaid expenses and other current assets 505,924 1,502,725
Total current assets 27,986,393 42,469,999
Equipment and improvements 241,574
Right-of-use asset 353,250
Total assets 28,581,217 42,469,999
Current liabilities:    
Accounts payable 781,223 1,089,778
Lease obligation, current 142,048
Accrued expenses and other current liabilities 2,289,726 2,715,761
Notes payable 0 248,911
Total current liabilities 3,212,997 4,054,450
Lease obligations 232,020
Total liabilities 3,445,017 4,054,450
Commitments and contingencies (see Note 15)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 25,227,051 and 25,155,198 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 25,227 25,155
Additional paid-in capital 68,676,935 68,208,081
Accumulated other comprehensive income 26,828 0
Accumulated deficit (43,592,790) (29,817,687)
Total stockholders' equity 25,136,200 38,415,549
Total liabilities and stockholders' equity $ 28,581,217 $ 42,469,999

Source